Profile data is unavailable for this security.
About the company
Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with an intended application, which includes the treatment of hypoxic conditions in the brain resulting from stroke. The Company, through its subsidiary, Pharmalectin Inc., is focused on the development, manufacturing, and commercialization of therapeutic drugs designed to address viral diseases in humans. Pharmalectin Inc. has developed a method designed to reduce the viral load and modulate the immune system using a galectin inhibitor. Its lead drug candidate, named ProLectin-Rx, is a complex polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin.
- Revenue in USD (TTM)0.00
- Net income in USD-2.90m
- Incorporated2008
- Employees2.00
- LocationBioxytran Inc75 2Nd Ave, Suite 605 Ste 605NEEDHAM 02494United StatesUSA
- Phone+1 (617) 494-1199
- Websitehttps://www.bioxytraninc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pulmatrix Inc | 11.39m | -10.84m | 7.49m | 22.00 | -- | 0.5625 | -- | 0.6572 | -2.97 | -2.97 | 3.12 | 3.64 | 0.483 | -- | 21.64 | 517,818.20 | -45.97 | -46.91 | -52.76 | -58.12 | -- | -- | -95.18 | -238.04 | -- | -- | 0.00 | -- | 20.21 | 116.62 | 25.03 | -- | 104.29 | -- |
| Moleculin Biotech Inc | 0.00 | -25.17m | 7.51m | 18.00 | -- | 0.3818 | -- | -- | -11.62 | -11.62 | 0.00 | 6.91 | 0.00 | -- | -- | 0.00 | -69.24 | -46.84 | -83.35 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
| Kineta Inc | 0.00 | -20.88m | 7.60m | 11.00 | -- | -- | -- | -- | -1.79 | -1.79 | 0.00 | -0.6638 | 0.00 | -- | -- | 0.00 | -220.35 | -66.16 | -- | -86.61 | -- | -- | -- | -854.74 | -- | -- | -- | -- | 178.65 | 13.89 | 77.76 | -- | -- | -- |
| Plus Therapeutics Inc (USA) | 5.51m | -13.23m | 7.61m | 20.00 | -- | -- | -- | 1.38 | -3.05 | -3.05 | 1.19 | -1.34 | 0.4336 | -- | -- | 275,450.00 | -104.14 | -59.18 | -- | -133.04 | -- | -- | -240.15 | -470.45 | -- | -4.17 | -- | -- | 2,093.30 | -5.89 | 34.32 | -- | 3.77 | -- |
| NLS Pharmaceutics AG | 0.00 | -6.60m | 7.72m | 3.00 | -- | -- | -- | -- | -6.72 | -6.72 | 0.00 | -9.40 | 0.00 | -- | -- | 0.00 | -380.82 | -272.62 | -- | -- | -- | -- | -- | -- | -- | -27.20 | -- | -- | -- | -- | 26.21 | -- | -- | -- |
| Alterola Biotech Inc | 0.00 | -2.06m | 7.74m | 1.00 | -- | -- | -- | -- | -0.0017 | -0.0017 | 0.00 | -0.001 | 0.00 | -- | -- | 0.00 | -32.46 | -- | -46.53 | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | -- | -- | -14.64 | -- | -- | -- |
| Edesa Biotech Inc | 0.00 | -6.93m | 7.76m | 16.00 | -- | 2.71 | -- | -- | -2.21 | -2.21 | 0.00 | 0.8829 | 0.00 | -- | -- | 0.00 | -94.60 | -- | -128.81 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 7.95m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Vitro Biopharma Inc | 1.85m | -9.72m | 8.05m | 10.00 | -- | -- | -- | 4.35 | -2.18 | -2.18 | 0.4159 | -1.64 | 0.2324 | 1.58 | 24.96 | 185,140.00 | -122.00 | -- | -1,146.77 | -- | 82.88 | -- | -524.87 | -- | 0.169 | -5.37 | 5.49 | -- | -46.45 | -- | 31.01 | -- | -- | -- |
| Forte Biosciences Inc | 0.00 | -35.76m | 8.29m | 11.00 | -- | 0.4879 | -- | -- | -22.03 | -22.03 | 0.00 | 11.64 | 0.00 | -- | -- | 0.00 | -124.89 | -72.06 | -170.91 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
| Bioxytran Inc | 0.00 | -2.90m | 8.30m | 2.00 | -- | -- | -- | -- | -0.0188 | -0.0188 | 0.00 | -0.0132 | 0.00 | -- | -- | -- | -1,687.15 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -17.23 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| BioCardia Inc | 428.00k | -8.56m | 8.40m | 16.00 | -- | -- | -- | 19.64 | -5.40 | -5.40 | 0.2636 | -0.9233 | 0.0923 | -- | 6.85 | 26,750.00 | -184.48 | -107.34 | -1,075.25 | -154.17 | -- | -- | -1,999.77 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Intelligent Bio Solutions Inc | 3.11m | -10.16m | 8.51m | 13.00 | -- | 0.8049 | -- | 2.73 | -39.72 | -39.72 | 2.31 | 2.41 | 0.2579 | 1.92 | 8.60 | 239,366.90 | -84.45 | -71.59 | -156.10 | -144.36 | 45.81 | -- | -327.50 | -565.48 | 1.42 | -- | 0.0592 | -- | 147.58 | 596.39 | 4.47 | -- | -- | -- |
| GlucoTrack Inc | 0.00 | -12.05m | 8.60m | 6.00 | -- | -- | -- | -- | -2.42 | -2.42 | 0.00 | -0.6004 | 0.00 | -- | -- | 0.00 | -251.32 | -94.01 | -493.89 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | -- | -- | -- | -- | -60.02 | -- | -- | -- |
| Virax Biolabs Group Ltd | 156.42k | -6.73m | 8.72m | 17.00 | -- | 1.03 | -- | 55.73 | -3.35 | -3.35 | 0.078 | 2.09 | 0.0205 | 3.51 | -- | 9,201.18 | -88.11 | -- | -91.88 | -- | 32.34 | -- | -4,308.35 | -- | 25.58 | -227.16 | 0.0418 | -- | 1,727.34 | -- | -23.38 | -- | -- | -- |
| Soligenix Inc | 494.62k | -7.04m | 9.16m | 13.00 | -- | 1.62 | -- | 18.52 | -9.58 | -9.58 | 0.6152 | 2.25 | 0.0418 | -- | 8.70 | 38,047.69 | -59.45 | -75.40 | -121.64 | -154.32 | 8.75 | 22.83 | -1,423.81 | -620.02 | -- | -- | 0.4421 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
